1370046-40-4 Usage
Uses
Used in Pharmaceutical Industry:
3-phenyl-5-(3,4,5-tri-OCH3-phenyl)-4,5-dihydro 1H-pyrazole-1-carbothioamide is used as a potential pharmaceutical agent for its possible biological activity. 3-phenyl-5-(3,4,5,-tri-OCH3-phenyl)-4,5-dihydro 1H-pyrazole-1-carbothioamide's unique structure may contribute to its interaction with biological targets, offering therapeutic benefits that could be harnessed in the development of new drugs.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, 3-phenyl-5-(3,4,5-tri-OCH3-phenyl)-4,5-dihydro 1H-pyrazole-1-carbothioamide serves as a subject of study for its potential to influence biological systems. Researchers may investigate its binding affinity, selectivity, and mechanism of action to understand how it could be utilized in the treatment of various diseases or conditions.
Used in Drug Design and Development:
3-phenyl-5-(3,4,5-tri-OCH3-phenyl)-4,5-dihydro 1H-pyrazole-1-carbothioamide is utilized in drug design and development processes to explore its potential as a lead compound. Its structural features may provide insights into the design of more effective and selective therapeutic agents, contributing to advancements in medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 1370046-40-4 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,7,0,0,4 and 6 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1370046-40:
(9*1)+(8*3)+(7*7)+(6*0)+(5*0)+(4*4)+(3*6)+(2*4)+(1*0)=124
124 % 10 = 4
So 1370046-40-4 is a valid CAS Registry Number.
1370046-40-4Relevant articles and documents
Synthesis, spectroscopic characterization, in vitro cytotoxic and structure activity relationships of some mononuclear Ru(II) complexes
Thota, Sreekanth,Vallala, Srujana,Imran, Mohammad,Mekala, Sravani,Anchuri, Shyam Sunder,Karki, Subhas Somalingappa,Yerra, Rajeshwar,Balzarini, Jan,De Clercq, Erik
, p. 1031 - 1045 (2013)
New mononuclear Ru(II) complexes [Ru(A)2(B)}2+, where A= 2,2'-bipyridine/1,10-phenanthroline and B= 3,4,5-tri-OCH3-DPC, 4-CH3-DPC, 4-N(CH3)2-DPC, 4-NO2-DPC, N-BITSZ, PTSZ and PINH, were prepared and characterized by spectroscopic methods. The in vitro cytotoxic activities of the complexes and their corresponding ligands were investigated against the human cancer TlyMPhocyte cell lines molt 4/c8 and CEM and the murine tumor leukemia cell line L1210, human promyelocytic leukemia cells (HL-60) and Bel-7402 liver cancer cells by MTT assay. The complexes [Ru(A)2(B)}2+ (A= 1,10-phenanthroline, B= 3,4,5-tri-OCH3-DPC) exerts rather more potent activities against all of these cell lines, especially for CEM and L1210. Ru complexes and structure-activity relationships and anticancer mechanisms are also discussed.
